Form 4: Cirrus Logic EVP Exercises Options, Sells Shares
Insider Transaction Report
Cirrus Logic's EVP of R&D, Jeffrey W. Baumgartner, executed a pre-planned transaction, exercising stock options and selling common stock.
Summary
- Jeffrey W. Baumgartner, EVP, R&D of Cirrus Logic, Inc. (CRUS), engaged in a pre-planned transaction on September 2, 2025.
- The transaction was executed under a Rule 10b5-1 plan adopted on August 20, 2024.
- Exercised 10,000 non-qualified stock options at an exercise price of $38.34 per share.
- Concurrently sold 10,000 shares of common stock at a weighted average price of $111.7811 per share.
- The sale involved multiple transactions with prices ranging from $111.05 to $112.47.
- Following these transactions, beneficial ownership of common stock decreased to 14,001 shares, and derivative securities (options) decreased to 7,391.
Sentiment
Score: 6
Explanation: The filing reports a routine, pre-planned insider transaction (exercise of options and sale of shares) under a Rule 10b5-1 plan. While an executive selling shares can sometimes be viewed negatively, the pre-planned nature mitigates this. The executive realized a substantial profit, which is a positive for the individual but neutral for the company's immediate outlook.
Positives
- The executive realized a significant profit from exercising options and selling shares, with the sale price substantially higher than the exercise price ($111.7811 vs. $38.34).
- The transaction was conducted under a pre-arranged Rule 10b5-1 plan, indicating a planned liquidity event rather than a reaction to new, non-public information.
Negatives
- An executive selling shares, even under a 10b5-1 plan, can sometimes be perceived by the market as a lack of confidence, though this is mitigated by the pre-planned nature.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The sale of 10,000 shares by an executive represents a minor increase in the public float. The pre-planned nature under Rule 10b5-1 suggests it is a personal liquidity event rather than a signal about company performance.
Key Dates
| Date | Description |
|---|---|
| 05/02/2019 | 25% of non-qualified stock options vested. |
| 05/02/2022 | Remaining non-qualified stock options fully vested and exercisable. |
| 08/20/2024 | Rule 10b5-1 plan adopted by the reporting person. |
| 09/02/2025 | Date of option exercise and common stock sale transactions. |
| 09/03/2025 | Date of filing signature. |
| 05/02/2028 | Expiration date of the non-qualified stock option. |
Keywords
Cirrus Logic, CRUS, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Jeffrey Baumgartner, 10b5-1 Plan, Executive Compensation, Equity Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.